EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

被引：0

作者：

Gumus, Mahmut

Geredeli, Caglayan

Ucar, Mahmut

Kaya, Serap

Demir, Hacer

Unal, Olcun Umit

Degirmenci, Mustafa

Dogu, Gamze Gokoz

Turan, Nedim

Yildirim, Nilgun

Basal, Fatma Bugdayci

Arpaci, Erkan

Karaagac, Mustafa

Harputluoglu, Hakan

Turk, Had Mehmet

Dane, Faysal

Ozkan, Metin

机构：

[1] Istanbul Medeniyet Univ Hosp, Dept Med Oncol, Istanbul, Turkey

[2] Okmeydani Training & Res Hosp, Dept Med Oncol, Istanbul, Turkey

[3] Erciyes Univ, Dept Med Oncol, Kayseri, Turkey

[4] Marmara Univ, Med Oncol, Istanbul, Turkey

[5] Gazi Univ, Fac Med, Med Oncol Clin, Ankara, Turkey

[6] Ataturk Training & Res Hosp, Izmir, Turkey

[7] Tepecik Educ & Res Hosp, Izmir, Turkey

[8] Pamukkale Univ, Denizli, Turkey

[9] Cumhuriyet Univ, Sch Med, Dept Med Oncol, Sivas, Turkey

[10] Ataturk Univ, Dept Med Oncol, Erzurum, Turkey

[11] Ankara Numone Training & Res Hosp, Dept Med Oncol, Ankara, Turkey

[12] Bulent Ecevit Univ, Zonguldak, Turkey

[13] Konya Necmeddin Erbakan Univ, Meram Sch Med, Diyarbakir, Turkey

[14] Inonu Univ, Dept Med Oncol, Fac Med, Malatya, Turkey

[15] Bezmialem Univ, Med Oncol, Istanbul, Turkey

[16] Erciyes Univ, Dept Med Oncol, Kayseri, Turkey

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.e15028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e15028

引用

页数：6

共 50 条

[21] Insights into the pathophysiology and management of dermatologic toxicities to EGFR-targeted therapies in colorectal cancer
Lacouture, Mario E.
CANCER NURSING, 2007, 30 (04) : S17 - S26
[22] A systems approach to identifying patient responders to EGFR-targeted therapy of colorectal cancer
Schoeberl, B.
Harms, B.
Grantcharova, V.
Stewart, E.
Nielsen, U.
EJC SUPPLEMENTS, 2006, 4 (12): : 196 - 196
[23] KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy
Valtorta, Emanuele
Misale, Sandra
Sartore-Bianchi, Andrea
Nagtegaal, Iris D.
Paraf, Francois
Lauricella, Calogero
Dimartino, Valentina
Hobor, Sebastijan
Jacobs, Bart
Ercolani, Cristiana
Lamba, Simona
Scala, Elisa
Veronese, Silvio
Laurent-Puig, Pierre
Siena, Salvatore
Tejpar, Sabine
Mottolese, Marcella
Punt, Cornelis J. A.
Gambacorta, Marcello
Bardelli, Alberto
Di Nicolantonio, Federica
INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (05) : 1259 - 1265
[24] Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
David Z Chang
Vikas Kumar
Ying Ma
Kuiyuan Li
Scott Kopetz
Journal of Hematology & Oncology, 2
[25] Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer
Sartore-Bianchi, Andrea
Valtorta, Emanuele
Amatu, Alessio
Veronese, Silvio
Lauricella, Calogero
Bonazzina, Erica
Siravegna, Giulia
Truini, Mauro
Bardelli, Alberto
Siena, Salvatore
ESMO OPEN, 2016, 1 (04)
[26] Panitumumab - In the treatment of metastatic colorectal cancer
Hoy, Sheridan M.
Wagstaff, Antona J.
DRUGS, 2006, 66 (15) : 2005 - 2014
[27] Metastatic colorectal cancer: treatment with panitumumab
Silvinato, Antonio
Pedreira, Isabela da Silveira
Bueno dos Reis, Joao Conrado
Zetula Marcondes, Joao Guilherme
Bernardo, Wanderley M.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2018, 64 (07): : 568 - 574
[28] Overcoming resistance to EGFR-targeted therapies in cancer
Laffman-Johnson, Elise
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (02) : 120 - 120
[29] Panitumumab for the treatment of metastatic colorectal cancer
Pinguet, Frederic
EJHP PRACTICE, 2009, 15 (06): : 66 - 69
[30] Spotlight on Panitumumab in Metastatic Colorectal Cancer
Keating, Gillian M.
BIODRUGS, 2010, 24 (04) : 275 - 278

← 1 2 3 4 5 →